UPLIZNA Offers gMG Patients Deep and Durable Symptom Control and Twice-Yearly Dosing* First and Only CD19-Targeted B Cell Therapy Approved in anti-AChR and anti-MuSK ...
In the food and beverage industry, both utility and design patents can be vital to intellectual property protection. They allow companies to mark their products as ...
Facing backlash over recent policy wording, the Coast Guard moved Thursday to make one thing clear: "hate symbols" such as swastikas and nooses remain forbidden in the service. The Coast Guard ...
The U.S. Coast Guard has released a new, firmer policy addressing the display of hate symbols like swastikas and nooses just hours after it was publicly revealed that it made plans to describe them as ...
Pfizer and manufacturer Tris Pharma have agreed to hand over $41.5 million to lay to rest a 2023 lawsuit accusing the companies of knowingly providing compromised ...
While the FDA is streamlining regulation of copycat versions of the expensive drugs that millions take for arthritis, cancer, and other diseases, the U.S. patent office is making it harder for the ...
Patent adds to Envoy Medical’s expanding intellectual property portfolio, reinforcing the Company’s leadership in next generation cochlear implant innovation White Bear Lake, Minnesota--(Newsfile Corp ...
In our latest IPWatchdog Unleashed podcast, I spoke with Rob Sahr, shareholder at Wolf Greenfield and co-chair of our 2025 Life Sciences Masters™ program. Our conversation zeroed in on a hard truth ...
ERIC urges the USPTO to withdraw the rule and collaborate on a patent process that promotes competition, lowers costs and improves access to medicines. Gelfand added, "We urge the USPTO to withdraw ...
Sevabertinib received accelerated FDA approval for HER2 TKD-mutant nonsquamous NSCLC, showing a 71% ORR in the SOHO-01 trial. The treatment demonstrated a tolerable safety profile, with diarrhea as ...
Sandoz Inc. convinced the Federal Circuit to reverse a $39 million Colorado jury verdict over a Duke University and Allergan Sales LLC patent for a topical eyelash hair-loss treatment because the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback